Concepedia

Anusara Daenthanasanmak

AD

24

Publications

1.1K

Citations

18

H-Index

2012

Active since

Affiliations

Medical University of South Carolina(Current)

National Cancer Institute

National Institutes of Health

Rutgers, The State University of New Jersey

Center for Cancer Research

Anusara Daenthanasanmak is an author at Medical University of South Carolina specializing in cell biology, immunology, and medicine.

ORCID

Top concepts

Publications per year

2012–2023

24

Publications

24

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Shilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty et al. · Cell Metabolism · 2017 · 251 citations · Full text

, , +9

Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation

Hung Nguyen, Shilpak Chatterjee, Kelley M.K. Haarberg et al. · Journal of Clinical Investigation · 2016 · 122 citations · Full text

, , +25

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

Brian C. Betts, David Bastian, Supinya Iamsawat et al. · Proceedings of the National Academy of Sciences · 2018 · 74 citations · Full text

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty et al. · Blood · 2018 · 72 citations · Full text

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak et al. · Clinical Cancer Research · 2018 · 65 citations · Full text

Rows per page

1–5 of 24